Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

26.07.19	Notable Earnings To Watch Next Week - LLY, AAPL, PG, MRK, PFE, CVX (RTTNews)
23.07.19	FDA Approves Pfizer’s Biosimilar, RUXIENCE™ (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions (Businesswire)
03.07.19	ViiV Healthcare Reports Marketing Authorisation Of Dovato In Europe (RTTNews)
01.07.19	PFIZER SCHLIESST DIE AKQUISITION VON THERACHON AB (Businesswire)
01.07.19	Pfizer Completes Acquisition of Therachon (Businesswire)
01.07.19	Pfizer Reports Positive Findings From Phase 4 Crisaborole Study - Quick Facts (RTTNews)
01.07.19	Pfizer Announces Positive Top-Line Results from Phase 4 Study of Crisaborole Ointment, 2%, in Children Aged 3 Months to Less Than 24 Months with Mild to Moderate Atopic Dermatitis (Businesswire)
28.06.19	Pfizer Announces Results from Phase 3 Trial of Revatio® (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension (Businesswire)
28.06.19	Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy (DMD) (Businesswire)
28.06.19	FDA Approves Pfizer's Zirabev To Treat Five Types Of Cancer (RTTNews)
28.06.19	Pfizer Receives U.S. FDA Approval for Its Oncology Biosimilar, ZIRABEV™ (bevacizumab-bvzr) (Businesswire)
28.06.19	Former FDA Commissioner Scott Gottlieb Joins Pfizer Board - Quick Facts (RTTNews)
27.06.19	Scott Gottlieb Elected to Pfizer’s Board of Directors (Businesswire)
27.06.19	Pfizer Declares Third-Quarter 2019 Dividend (Businesswire)
21.06.19	European Commission Approves TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer (Businesswire)
18.06.19	Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts (Businesswire)
17.06.19	Pfizer To Acquire Array BioPharma In $11.4 Bln Deal - Quick Facts (RTTNews)
17.06.19	Pfizer to Acquire Array BioPharma (Businesswire)
12.06.19	Pfizer Says Study Supports Use Of Xeljanz Alone In Rheumatoid Arthritis (RTTNews)
12.06.19	Pfizer Announces Results from XELJANZ® XR (tofacitinib) ORAL Shift Study, The First Phase 3b/4 Study to Evaluate Methotrexate Withdrawal with a JAK Inhibitor (Businesswire)
11.06.19	FDA Approves World's Costliest Drug For SMA (RTTNews)
05.06.19	Jeff Settleman, Ph.D., Joins Pfizer to Lead Oncology Research & Development (Businesswire)
25.05.19	Biotech Stocks Facing FDA Decision In June 2019 (RTTNews)
24.05.19	Pfizer's Lyrica Fails To Meet Endpoint In Epilepsy Study (RTTNews)
24.05.19	Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA® (pregabalin) in Primary Generalized Tonic-Clonic Seizures (Businesswire)
15.05.19	Pfizer Oncology to Showcase New Data from Innovative Science That Address Patient Needs at ASCO 2019 Annual Meeting (Businesswire)
15.05.19	Pfizer's Phase 3 Study Of Abrocitinib Shows Positive Top-Line Results (RTTNews)
08.05.19	Pfizer Acquires Clinical-Stage Biotech Therachon (Businesswire)
07.05.19	European Commission Approves LORVIQUA® (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer (Businesswire)
06.05.19	Pfizer Says VYNDAQEL And VYNDAMAX Approved By FDA - Quick Facts (RTTNews)
06.05.19	U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease (Businesswire)
30.04.19	Pfizer Boosts FY19 Adj. EPS Outlook - Quick Facts (RTTNews)
30.04.19	Pfizer Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
30.04.19	PFIZER REPORTS FIRST-QUARTER 2019 RESULTS (Businesswire)
29.04.19	ViiV Healthcare Seeks FDA Approval For Two-drug To Treat HIV-1 Infection (RTTNews)
26.04.19	Pfizer Receives Positive CHMP Opinion for TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer (Businesswire)
25.04.19	Pfizer Hosts Annual Meeting of Shareholders (Businesswire)
18.04.19	Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis (Businesswire)
18.04.19	Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders (Businesswire)
09.04.19	GSK: FDA Approves ViiV Healthcare's Dovato - Quick Facts (RTTNews)
05.04.19	FDA Expands Use Of Metastatic Breast Cancer Treatment To Include Male Patients (RTTNews)
04.04.19	10 Best Selling Drugs Of 2018 (RTTNews)
03.04.19	VIZIMPRO® (dacomitinib) Receives Marketing Authorization in European Union (EU) for the First-Line Treatment of Adult Patients with EGFR-Mutated Non-Small Cell Lung Cancer (Businesswire)
02.04.19	Sangamo, Pfizer Report Promising Interim Results With SB-525 Gene Therapy (RTTNews)
02.04.19	Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy (Businesswire)
20.03.19	Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics (Businesswire)
20.03.19	Merck KGaA And Pfizer Discontinue Phase III JAVELIN Ovarian PARP 100 Trial (RTTNews)
19.03.19	Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts (Businesswire)
12.03.19	FDA Okays Pfizer's Trastuzumab Biosimilar, Trazimera (RTTNews)
12.03.19	U.S. FDA Approves Pfizer’s Oncology Biosimilar TRAZIMERA™ (trastuzumab-qyyp), a Biosimilar to Herceptin®1 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22:33		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
20:03		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
18:01		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
17:58		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen
17:58		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
17:58		Handel in Frankfurt: TecDAX letztendlich in Grün

22:33

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

20:03

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

18:01

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

17:58

Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

17:58

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

17:58

Handel in Frankfurt: TecDAX letztendlich in Grün